Comparing Safety and Effectiveness of Pfizer BA.4-5 and Sanofi bivalent COVID-19 Vaccines Used in the Spring 2023 Booster Programme in England: A Target Trial Emulation Study Using the OpenSAFELY Platform

被引：0

作者：

Hulme, William ^{[1
]}

Andrews, Colm ^{[1
]}

Prestige, Em ^{[2
]}

Parker, Edward ^{[2
]}

Walker, Venexia M. ^{[3
]}

Wood, Christopher ^{[1
]}

Smith, Becky ^{[1
]}

Schaffer, Andrea ^{[1
]}

Walker, Alex ^{[1
]}

Curtis, Helen ^{[1
]}

MacKenna, Brian ^{[1
]}

Mehrkar, Amir ^{[4
]}

Goldacre, Ben ^{[4
]}

Hernan, Miguel A. ^{[5
]}

Sterne, Jonathan ^{[3
]}

机构：

[1] Univ Oxford, Bennett Inst Appl Data Sci, Nuffield Dept Primary Care Hlth Sci, Oxford, England

[2] London Sch Hyg & Trop Med, London, England

[3] Univ Bristol, Bristol, Avon, England

[4] Univ Oxford, Oxford, England

[5] Karolinska Inst, Inst Environm Med, Epidemiol Unit, CAUSALab, Stockholm, Sweden

来源：

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2024年 / 33卷

关键词：

D O I：

暂无

中图分类号：

R1 [预防医学、卫生学];

学科分类号：

1004 ; 120402 ;

摘要：

引用

页码：12 / 13

页数：2

共 5 条

[1] Bivalent COVID-19 booster vaccines and the absence of BA.5-specific antibodies (vol 4, pg e569, 2023)
Carreno, J. M.
Singh, G.
Simon, V
Krammer, F.
LANCET MICROBE, 2023, 4 (08): : E576 - E576
[2] Effectiveness of monoclonal antibodies and antivirals against severe COVID-19 outcomes in community settings in England: An emulated target trial using the openSAFELY platform
Tazare, John R.
Nab, Linda
Zheng, Bang
Green, Amelia
Curtis, Helen
Hulme, William
Walker, Alex
Schultze, Anna
Bhaskaran, Krishnan
Evans, Stephen
Goldacre, Ben
MacKenna, Brian
Douglas, Ian
Tomlinson, Laurie
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2022, 31 : 423 - 424
[3] Effectiveness against severe COVID-19 of a seasonal booster dose of bivalent (original/Omicron BA.4-5) mRNA vaccines in persons aged ≥ 60 years: Estimates over calendar time and by time since administration during prevalent circulation of different Omicron subvariants, Italy, 2022-2023-2023
Fabiani, Massimo
Mateo-Urdiales, Alberto
Sacco, Chiara
Fotakis, Emmanouil Alexandros
Battilomo, Serena
Petrone, Daniele
Del Manso, Martina
Bella, Antonino
Riccardo, Flavia
Stefanelli, Paola
Palamara, Anna Teresa
Pezzotti, Patrizio
VACCINE, 2024, 42 (23)
[4] Relative effectiveness of bivalent Original/Omicron BA.4-5 mRNA vaccine in preventing severe COVID-19 in persons 60 years and above during SARS-CoV-2 Omicron XBB.1.5 and other XBB sublineages circulation, Italy, April to June 2023
Fabiani, Massimo
Mateo-Urdiales, Alberto
Sacco, Chiara
Cristina, Maria
Fotakis, Emmanouil Alexandros
Petrone, Daniele
Del Manso, Martina
Siddu, Andrea
Stefanelli, Paola
Bella, Antonino
Riccardo, Flavia
Rezza, Giovanni
Palamara, Anna Teresa
Brusaferro, Silvio
Pezzotti, Patrizio
EUROSURVEILLANCE, 2023, 28 (32) : 2 - 8
[5] References 1 Patel P, Hiam L, Sowemimo A, Devakumar D, McKee M. Ethnicity and covid-19. BMJ. 2020;369:m2282. 2 Pareek M, Bangash MN, Pareek N, et al. Ethnicity and COVID-19: an urgent public health research priority. Lancet. 2020;395(10234): 1421-1422. 3 Khunti K, Singh AK, Pareek M, Hanif W. Is ethnicity linked to incidence or outcomes of COVID-19? BMJ. 2020;369:m1548. 4 Mathur R, Rentsch CT, Morton CE, et al. Ethnic differences in SARS-CoV-2 infection and COVID-19-related hospitalisation, intensive care unit admission, and death in 17 million adults in England: an observational cohort study using the OpenSAFELY platform. Lancet. 2021;397(10286):1711-1724. 5 Public Health England. Disparities in the risk and outcomes of COVID-19. 2020. 6 Office for National Statistics. Updating ethnic contrasts in deaths involving the coronavirus (COVID-19), England: 24 January 2020 to 31 March 2021. 2021.
Irizar, Patricia
Pan, Daniel
Kapadia, Dharmi
Becares, Laia
Sze, Shirley
Taylor, Harry
Amele, Sarah
Kibuchi, Eliud
Divall, Pip
Gray, Laura J.
Nellums, Laura B.
Katikireddi, Srinivasa Vittal
Pareek, Manish
ECLINICALMEDICINE, 2023, 57

← 1 →